Mean weight change from baseline for patients who entered the OLE study, by prior double-blind phase 3 study treatment. 06–010 is the OLE of the DB phase 3 trials (placebo patients in the DB phase were initiated on active treatment at the start of the OLE phase). DB, double-blind; OLE, open-label extension; SEM, standard error of the mean; SXB, sodium oxybate.
Spaeth et al. Arthritis Research & Therapy 2013 15:R185 doi:10.1186/ar4375